Droxia Capsule
Product Images NDC 80725-820

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Droxia (NDC 80725-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Droxia 01)

Chemical Structure (Droxia 01)
Chemical structure of Hydroxyurea, showing the arrangement of atoms including amine, carbonyl, and hydroxyl functional groups.*
FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Label)

Principal Display Panel (200 mg Capsule Bottle Label)
Label for DROXIA 200 mg capsules, containing hydroxyurea as the active ingredient. The label indicates 60 capsules per container, prescription use only (Rx only), and cautions that it is a cytotoxic agent. The labeler is Waylis Therapeutics LLC, with a barcode and relevant storage instructions.*
FDA Label Image

Principal Display Panel (300 mg Capsule Bottle Label)

Principal Display Panel (300 mg Capsule Bottle Label)
Label for DROXIA hydroxyurea capsules, USP, 300 mg strength. The label indicates the product contains 60 capsules, is prescription-only, and is a cytotoxic agent. It is manufactured by Waylis Therapeutics LLC and includes a caution to wear disposable gloves when handling. The label also features a barcode and storage instructions.*
FDA Label Image

Principal Display Panel (400 mg Capsule Bottle Label)

Principal Display Panel (400 mg Capsule Bottle Label)
DROXIA 400 mg capsules label containing hydroxyurea as the active ingredient. The label specifies 60 capsules per container, with the NDC number 80725-840-60. It indicates the product is prescription-only and cautions that it is a cytotoxic agent. The labeler is Waylis Therapeutics LLC, with manufacturing noted in Italy. Additional handling precautions and storage instructions are partially visible on the left side of the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.